Is Alnylam Pharmaceuticals a millionaire maker?

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...
The Manila Times

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with ...

Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92% of patients with untreated indolent non-Hodgkin lymphoma (iNHL) comparing favorably to an approx ...
China DailyOpinion

Modernization journey

As the world enters an era of geopolitical uncertainty, political polarization and rapid technological change, China is ...

Revalia Bio Awarded Up To $26.7 Million ARPA-H Contract Award to Advance Drug Development with Human Data Trials

Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

Gucci launches ‘UNITY’ handbag to support Melania Trump’s effort to help foster kids

Gucci heiress Alexandra Gucci Zarini touts new partnership with Melania Trump, directing ‘UNITY’ bag proceeds to the ...

Gucci heiress launches ‘UNITY’ handbag to support Melania Trump’s effort to help foster kids

Gucci heiress Alexandra Gucci Zarini touts new partnership with Melania Trump, directing ‘UNITY’ bag proceeds to the ...